Literature DB >> 5675434

The enzymatic nature of C'1r. Conversion of C'1s to C'1 esterase and digestion of amino acid esters by C'1r.

G B Naff, O S Ratnoff.   

Abstract

Human C'1, a macromolecular complex composed of three subunits, is the zymogen for at least two distinct enzymes. Preparations of one subunit, C'1r, functioned as a protease which converted another subunit, C'1s, to C'1 esterase. The conversion of C'1s to C'1 esterase by C'1r was blocked by Liquoid, phenyl methylsulfonyl fluoride, and calcium ions, but not by soybean trypsin inhibitor, hirudin, or heparin. Preparations of C'1r also possessed two additional functions, i.e., the ability to hydrolyze certain synthetic amino acid esters and to participate in immune hemolysis. Evidence was presented which indicates that these three functions are properties of a single entity, C'1r, but not of the same portion of its molecular structure. These observations suggest that C'1r has at least two active sites, one for its reaction with C'1q, an additional subunit of C'1, and one for its reaction with C'1s; together, the three subcomponents, C'1q, C'1r, and C'1s, form a single functional unit, the first component of complement.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5675434      PMCID: PMC2138543          DOI: 10.1084/jem.128.4.571

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  18 in total

1.  STUDIES ON HUMAN C'1-ESTERASE. I. PURIFICATION AND ENZYMATIC PROPERTIES.

Authors:  A L HAINES; I H LEPOW
Journal:  J Immunol       Date:  1964-03       Impact factor: 5.422

2.  Purification of thrombin by chromatography.

Authors:  P S RASMUSSEN
Journal:  Biochim Biophys Acta       Date:  1955-01

3.  Investigation of serum trypsin and related substances. I. The quantitative demonstration of trypsinlike activity in human blood serum by a micromethod.

Authors:  A M SIEGELMAN; A S CARLSON; T ROBERTSON
Journal:  Arch Biochem Biophys       Date:  1962-04       Impact factor: 4.013

4.  [Complement reactivation after poisoning with high molecular anticoagulants].

Authors:  P KLEIN; A LANGE
Journal:  Z Hyg Infektionskr       Date:  1956

5.  Concerning the mechanism of complement action. II. The nature of the first component of guinea pig complement.

Authors:  E L BECKER
Journal:  J Immunol       Date:  1956-12       Impact factor: 5.422

6.  Experiments on the nature of the prothrombin-converting principle: alteration of proaccelerin by thrombin.

Authors:  C R Prentice; O D Ratnoff; R T Breckenridge
Journal:  Br J Haematol       Date:  1967-11       Impact factor: 6.998

7.  Some properties of an esterase derived from preparations of the first component of complement.

Authors:  O D RATNOFF; I H LEPOW
Journal:  J Exp Med       Date:  1957-08-01       Impact factor: 14.307

8.  The conversion of C'IS to C'1 esterase by plasmin and trypsin.

Authors:  O D Ratnoff; G B Naff
Journal:  J Exp Med       Date:  1967-02-01       Impact factor: 14.307

9.  THE MACROMOLECULAR NATURE OF THE FIRST COMPONENT OF HUMAN COMPLEMENT.

Authors:  G B NAFF; J PENSKY; I H LEPOW
Journal:  J Exp Med       Date:  1964-04-01       Impact factor: 14.307

10.  Chromatographic resolution of the first component of human complement into three activities.

Authors:  I H LEPOW; G B NAFF; E W TODD; J PENSKY; C F HINZ
Journal:  J Exp Med       Date:  1963-06-01       Impact factor: 14.307

View more
  22 in total

1.  Modification of beta-2-microglobulin in sera from patients with small cell lung cancer: evidence for involvement of a serine protease.

Authors:  M H Nissen; O J Bjerrum; T Plesner; M Wilken; M Rørth
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

2.  Isolation and characterization of C1q, a subcomponent of the first component of complement, from human and rabbit sera.

Authors:  K B Reid; D M Lowe; R R Porter
Journal:  Biochem J       Date:  1972-12       Impact factor: 3.857

3.  Conversion of the fourth complement component studied by crossed immunoelectrophoresis.

Authors:  A G Sjöholm; A B Laurell
Journal:  Clin Exp Immunol       Date:  1973-08       Impact factor: 4.330

4.  C1r, subunit of the first complement component: purification, properties, and assay based on its linking role.

Authors:  M M De Bracco; R M Stroud
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808

5.  Initiation of complement activation.

Authors:  P J Lachmann; N C Hughes-Jones
Journal:  Springer Semin Immunopathol       Date:  1984

6.  The relationship between the binding ability and the rate of activation of the complement component C1.

Authors:  E J Folkerd; B Gardner; N C Hughes-Jones
Journal:  Immunology       Date:  1980-09       Impact factor: 7.397

7.  C1 inactivator inhibition by plasmin.

Authors:  P C Harpel
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

8.  In vitro activation of C1s in plasma of patients with hereditary angioneurotic oedema.

Authors:  S Shafiasghar; R H Cormane; K W Pondman
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

9.  Isolation and characterization of a low molecular weight complement inhibitor present in normal human serum.

Authors:  P J Baker; S G Osofsky
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

10.  The catalytic chain of human complement subcomponent C1r. Purification and N-terminal amino acid sequences of the major cyanogen bromide-cleavage fragments.

Authors:  G J Arlaud; J Gagnon; R R Porter
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.